Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-9560
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome ; volume:14 ; number:1 ; day:4 ; month:10 ; year:2016 ; pages:159-163 ; date:10.2016
Thrombosis journal ; 14, Heft 1 (4.10.2016), 159-163, 10.2016
- Urheber
-
El-Assaad, Fatima
- Beteiligte Personen und Organisationen
-
Krilis, Steven A.
Giannakopoulos, Bill
SpringerLink (Online service)
- DOI
-
10.1186/s12959-016-0115-z
- URN
-
urn:nbn:de:1111-201610303818
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- El-Assaad, Fatima
- Krilis, Steven A.
- Giannakopoulos, Bill
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of beta2-Glycoprotein I Post-translational Modifications on Protein Conformational Dynamics and Immunogenicity in the Context of the Antiphospholipid Syndrome
Post-translational modification in the pathogenesis of vitiligo
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
Co- and posttranslational engineering of the therapeutic glycoprotein erythropoietin with unnatural amino acids
Crystal structure of human β2-glycoprotein I:implications for phospholipid binding and the antiphospholipid syndrome
![Untersuchungen zur Diagnose eines Antiphospholipid-Syndroms durch Bestimmung von Cardiolipin und β2-Glycoprotein [Beta-2-Glycoprotein] I-Antikörper](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Untersuchungen zur Diagnose eines Antiphospholipid-Syndroms durch Bestimmung von Cardiolipin und β2-Glycoprotein [Beta-2-Glycoprotein] I-Antikörper
Antiphospholipid-Syndrom – Präeklampsie und antiphospholipid-Antikörper
The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
The mTOR pathway in the antiphospholipid syndrome
Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
Novel insights into the roles of glycoprotein B and pUS3 during equine herpesvirus pathogenesis
Impact of beta2-Glycoprotein I Post-translational Modifications on Protein Conformational Dynamics and Immunogenicity in the Context of the Antiphospholipid Syndrome
Post-translational modification in the pathogenesis of vitiligo
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
Co- and posttranslational engineering of the therapeutic glycoprotein erythropoietin with unnatural amino acids
Crystal structure of human β2-glycoprotein I:implications for phospholipid binding and the antiphospholipid syndrome
Untersuchungen zur Diagnose eines Antiphospholipid-Syndroms durch Bestimmung von Cardiolipin und β2-Glycoprotein [Beta-2-Glycoprotein] I-Antikörper
Antiphospholipid-Syndrom – Präeklampsie und antiphospholipid-Antikörper
The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
The mTOR pathway in the antiphospholipid syndrome
Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
Novel insights into the roles of glycoprotein B and pUS3 during equine herpesvirus pathogenesis
Impact of beta2-Glycoprotein I Post-translational Modifications on Protein Conformational Dynamics and Immunogenicity in the Context of the Antiphospholipid Syndrome
Post-translational modification in the pathogenesis of vitiligo
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
Co- and posttranslational engineering of the therapeutic glycoprotein erythropoietin with unnatural amino acids
Crystal structure of human β2-glycoprotein I:implications for phospholipid binding and the antiphospholipid syndrome
Untersuchungen zur Diagnose eines Antiphospholipid-Syndroms durch Bestimmung von Cardiolipin und β2-Glycoprotein [Beta-2-Glycoprotein] I-Antikörper
Antiphospholipid-Syndrom – Präeklampsie und antiphospholipid-Antikörper
The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
The mTOR pathway in the antiphospholipid syndrome
Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus